Active ingredientAvasimibeCat. No. P-A220-001CAS 166518-60-1Family · Pharmaceutical analytical standards
Avasimibe
An inhibitor of the ACAT (SOAT) enzyme, which turns cholesterol into its storage form: designed in the early 1990s, it was studied for high cholesterol and atherosclerosis until 2003, without ever reaching the market. This family brings together the active ingredient and labelled standards.
Did you know?Besides blocking ACAT it activates the nuclear receptor PXR and speeds up the metabolism of many other drugs, with a profile similar to rifampicin; in recent years it has been studied in the laboratory as a possible anticancer agent.
Go to the active ingredient →Active ingredientAvasimibeCat. No. P-A220-001CAS 166518-60-1
Active ingredientAvasimibe Sodium saltCat. No. P-A220-002CAS 166518-61-2
Isotopically labelledAvasimibe-13C6Cat. No. P-A220-003CAS 324016-61-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.